Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

7.81% CAGR in Medical Device Manufacturing Outsourcing Market from 2021 to 2025|Technavio

NEW YORK, Oct. 18, 2021 /PRNewswire/ -- The medical device manufacturing outsourcing market is expected to grow by USD 27.12 billion and record a CAGR of 7.81% from 2021 to 2025, according to the latest market research report by Technavio. The growth can be mainly attributed to the growing focus of OEMs on reducing medical device manufacturing costs.

Download Free Sample Now to explore growth opportunities in the medical device manufacturing outsourcing market.

Key Players in Medical Device Manufacturing Outsourcing Market

Subscribe to our "Lite Plan" billed annually at USD 3000 that enables you to download 3 reports a year and view 3 reports every month.

Medical Device Manufacturing Outsourcing Market 2021-2025: Segmentation

The medical device manufacturing outsourcing market is driven by the growing focus of OEMs on reducing medical device manufacturing costs, growing complexities in product design and development, and emerging countries as preferred outsourcing destinations for medical device manufacturing.

Download Free Sample Report for more information about various segments as well as the trends, drivers, and challenges impacting the medical device manufacturing outsourcing market.

Related Reports:

Medical Device Manufacturing Outsourcing Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 7.81%

Market growth 2021-2025

USD 27.12 billion

Market structure


YoY growth (%)


Regional analysis

North America, Asia, Europe, and ROW

Performing market contribution

North America at 34%

Key consumer countries

US, China, Germany, Japan, and India

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Cadence Inc., Celestica Inc., Eurofins Scientific SE, Flex Ltd., Integer Holdings Corp., Jabil Inc., Nortech Systems Inc., Sanmina Corp., TE Connectivity Ltd., and Tecomet Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 08:10
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it is enhancing its Corporate Social Responsibility (CSR) Program in the U.S., making an initial commitment of $20 million its first year supporting...

at 08:10
Better Therapeutics, Inc. ("Better Therapeutics"; NASDAQ: BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Deepti...

at 08:10
Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird...

at 08:07
Curebase, a company committed to democratizing access to clinical studies, today announced that a newly released telemedicine feature of its decentralized clinical trial (DCT) platform has expanded patient access for its client Edesa Biotech, Inc., a...

at 08:05
CytRx Corporation ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today issued a presentation on Centurion BioPharma Corporation's...

at 08:05
Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, today reported positive topline results from VIVID, the company's Phase 2 study of...

News published on 18 october 2021 at 19:00 and distributed by: